Cargando…

Bisphosphonates Versus Denosumab for Prevention of Pathological Fracture in Advanced Cancers With Bone Metastasis: A Meta-analysis of Randomized Controlled Trials

Metastasis to the bone is one of the most common complications associated with advanced cancer. Patients with bone metastases are at risk of devastating skeletal related events, including pathological fractures. PURPOSE: The aim of this study was to analyze the efficacy of zoledronic acid (ZA) versu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Farii, Humaid, Frazer, Abbey, Farahdel, Leila, AlFayyadh, Faisal, Turcotte, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418898/ https://www.ncbi.nlm.nih.gov/pubmed/32769706 http://dx.doi.org/10.5435/JAAOSGlobal-D-20-00045

Ejemplares similares

Zoledronic Acid Versus Denosumab for Prevention of Spinal Cord Compression in Advanced Cancers With Spine Metastasis: A Meta-Analysis of Randomized Controlled Trials
por: Al Farii, Humaid, et al.
Publicado: (2019)

The effect of NSAIDs on postfracture bone healing: a meta-analysis of randomized controlled trials
por: Al Farii, Humaid, et al.
Publicado: (2021)

Revision Distal Femoral Replacement Using Custom-made Stem and Cone to Augment Proximal Fixation
por: AlFayyadh, Faisal, et al.
Publicado: (2023)

The Use of Photodynamic Bone Stabilization to Tamponade Bleeding in a Pathologic Humeral Shaft Fracture: A Case Report
por: Vemu, Sree M, et al.
Publicado: (2023)

The Role of Bisphosphonates Prior to Denosumab Treatment on Rebound Fractures: A Mini Review
por: Inojosa, Arthur Costa, et al.
Publicado: (2022)

Intramuscular hemangioma of the pretarsal orbicularis oculi muscle in an adult treated with intralesional bleomycin injections
por: AlAbdulhadi, Halla A., et al.
Publicado: (2022)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

Thirty-Day Mortality in COVID-19 Positive Patients With Hip Fractures: A Case-Series and Literature Review
por: Al Farii, Humaid, et al.
Publicado: (2020)

Management of Osteomyelitis in Sickle Cell Disease: Review Article
por: Al Farii, Humaid, et al.
Publicado: (2020)

Future of bisphosphonates and denosumab for men with advanced prostate cancer
por: Iranikhah, Maryam, et al.
Publicado: (2014)

Can denosumab be a substitute, competitor, or complement to bisphosphonates?
por: Kim, Su Young, et al.
Publicado: (2017)

Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2020)

Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
por: Diel, Ingo, et al.
Publicado: (2020)

Atypical Femoral Fracture in a Patient without Bisphosphonate or Denosumab Exposure-A Case Report
por: Georgiadis, George F., et al.
Publicado: (2021)

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
por: Kamimura, M., et al.
Publicado: (2016)

Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women
por: Augoulea, A., et al.
Publicado: (2017)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)

The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone
por: Weschenfelder, Wolfram, et al.
Publicado: (2021)

Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials
por: WANG, XIN, et al.
Publicado: (2014)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
por: Wu, Jiaqi, et al.
Publicado: (2018)

Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis
por: Benjamin, Biju, et al.
Publicado: (2016)

Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
por: Sydlik, Carmen, et al.
Publicado: (2020)

Denosumab-Induced Rebound Hypercalcemia Treated With Bisphosphonates in a Pediatric Patient
por: Gandolfi, Anne, et al.
Publicado: (2023)

Surgical Management of the Metastatic Spine Disease: A Review of the Literature and Proposed Algorithm
por: Al Farii, Humaid, et al.
Publicado: (2022)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2021)

Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment
por: Hu, Mimi I., et al.
Publicado: (2013)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
por: Walsh, Mary E., et al.
Publicado: (2021)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
por: Egbert, Ryan Carlisle, et al.
Publicado: (2017)

Radiotherapy, Bisphosphonates and Surgical Stabilization of Complete or Impending Pathologic Fractures in Patients with Metastatic Bone Disease
por: Wolanczyk, Michal J., et al.
Publicado: (2016)

Do bisphosphonates cause femoral insufficiency fractures?
por: Seraphim, Andreas, et al.
Publicado: (2012)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
por: Zhu, Yilin, et al.
Publicado: (2019)

Effects after starting or switching from bisphosphonate to romosozumab or denosumab in Japanese postmenopausal patients
por: Shimizu, Tomohiro, et al.
Publicado: (2021)

Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study
por: Marocco, Chiara, et al.
Publicado: (2021)

Atypical femoral fracture in a metastatic bone disease patient six months after discontinuation of denosumab received sequentially to previous bisphosphonate therapy - A case report
por: Georgiadis, George F., et al.
Publicado: (2021)

Pseudotumor after total disc replacement in the lumbar spine: A case report and review of the literature
por: AlZeedi, Muadh, et al.
Publicado: (2022)

Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
por: Takahashi, Momoko, et al.
Publicado: (2019)

Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis
por: Bhatt, Geetika, et al.
Publicado: (2014)

Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment
por: Razaq, Abdul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jddpcbdn0r7bnpdda3ffsi51b6